263 related articles for article (PubMed ID: 28225482)
1. A case report of posterior reversible encephalopathy syndrome in a patient receiving gemcitabine and cisplatin.
Cherniawsky H; Merchant N; Sawyer M; Ho M
Medicine (Baltimore); 2017 Feb; 96(8):e5850. PubMed ID: 28225482
[TBL] [Abstract][Full Text] [Related]
2. Delayed Gemcitabine-Induced Posterior Reversible Encephalopathy Syndrome.
Schaub JR; Tang SC
Am J Med Sci; 2021 Jun; 361(6):795-798. PubMed ID: 33888263
[TBL] [Abstract][Full Text] [Related]
3. Posterior reversible encephalopathy syndrome possibly induced by pemetrexed maintenance therapy for lung cancer: a case report and literature review.
Smets GJ; Loyson T; Van Paesschen W; Demaerel P; Nackaerts K
Acta Clin Belg; 2018 Oct; 73(5):382-388. PubMed ID: 29173113
[TBL] [Abstract][Full Text] [Related]
4. Gemcitabine-induced posterior reversible encephalopathy syndrome: a case report.
Cioffi P; Laudadio L; Nuzzo A; Belfiglio M; Petrelli F; Grappasonni I
J Oncol Pharm Pract; 2012 Jun; 18(2):299-302. PubMed ID: 22065198
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapy-related posterior reversible leukoencephalopathy syndrome.
Bhatt A; Farooq MU; Majid A; Kassab M
Nat Clin Pract Neurol; 2009 Mar; 5(3):163-9. PubMed ID: 19262592
[TBL] [Abstract][Full Text] [Related]
6. Gemcitabine-induced reversible posterior leukoencephalopathy syndrome: a case report and review of the literature.
Rajasekhar A; George TJ
Oncologist; 2007 Nov; 12(11):1332-5. PubMed ID: 18055853
[TBL] [Abstract][Full Text] [Related]
7. Atypical posterior reversible encephalopathy syndrome associated with chemotherapy with Bevacizumab, Gemcitabine and Cisplatin.
Dersch R; Stich O; Goller K; Meckel S; Dechent F; Doostkam S; Weiller C; Bardutzky J
J Neurol; 2013 May; 260(5):1406-7. PubMed ID: 23430165
[No Abstract] [Full Text] [Related]
8. Chemotherapy-associated Posterior Reversible Encephalopathy Syndrome: A Case Report and Review of the Literature.
How J; Blattner M; Fowler S; Wang-Gillam A; Schindler SE
Neurologist; 2016 Nov; 21(6):112-117. PubMed ID: 27801773
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapy induced reversible posterior leukoencephalopathy syndrome.
Connolly RM; Doherty CP; Beddy P; O'Byrne K
Lung Cancer; 2007 Jun; 56(3):459-63. PubMed ID: 17316891
[TBL] [Abstract][Full Text] [Related]
10. [Posterior reversible encephalopathy syndrome associated to chemotherapy. Gemcitabine as the causative agent].
Sanchez-Cendra C; Malon-Gimenez D; Guerra-Martinez JA; Calzas-Rodriguez J; Anton-Pascual B; Olmo-Sanchez A
Rev Neurol; 2017 Jun; 64(12):574-575. PubMed ID: 28608357
[TBL] [Abstract][Full Text] [Related]
11. Posterior reversible encephalopathy syndrome (PRES) induced by pazopanib, a multi-targeting tyrosine kinase inhibitor, in a patient with soft-tissue sarcoma: case report and review of the literature.
Deguchi S; Mitsuya K; Nakasu Y; Hayashi N; Katagiri H; Murata H; Wasa J; Takahashi M; Endo M
Invest New Drugs; 2018 Apr; 36(2):346-349. PubMed ID: 29067537
[TBL] [Abstract][Full Text] [Related]
12. Posterior reversible encephalopathy syndrome with spinal cord involvement but without hemisphere lesions: A case report.
Liu L; Dai D; Cao F; Zhang L; Wang X
Medicine (Baltimore); 2019 Jan; 98(2):e13649. PubMed ID: 30633153
[TBL] [Abstract][Full Text] [Related]
13. Chemotherapy-induced reversible posterior leucoencephalopathy syndrome.
Han CH; Findlay MP
Intern Med J; 2010 Feb; 40(2):153-9. PubMed ID: 20446957
[TBL] [Abstract][Full Text] [Related]
14. Posterior Reversible Encephalopathy Syndrome in Children:: A Prospective Follow-up Study.
Darwish AH
J Child Neurol; 2020 Jan; 35(1):55-62. PubMed ID: 31570037
[TBL] [Abstract][Full Text] [Related]
15. Gemcitabine and cisplatin chemotherapy induced reversible posterior leukoencephalopathy syndrome in a bladder cancer patient.
Maeda T; Kikuchi E; Matsumoto K; Yazawa S; Hagiuda J; Miyajima A; Nakagawa K; Fujiwara H; Hoshino H; Oya M
Int J Clin Oncol; 2010 Oct; 15(5):508-11. PubMed ID: 20352464
[TBL] [Abstract][Full Text] [Related]
16. Reversible posterior leukoencephalopathy syndrome associated with concurrent bevacizumab, gemcitabine, and oxaliplatin for cholangiocarcinoma.
Chang Y; Mbeo G; Littman SJ
J Gastrointest Cancer; 2012 Sep; 43(3):505-7. PubMed ID: 21556724
[TBL] [Abstract][Full Text] [Related]
17. Chemotherapy-induced posterior reversible encephalopathy syndrome: Three case reports.
Cacho-Díaz B; Lorenzana-Mendoza NA; Salmerón-Moreno K; Reyes-Soto G; Castillo-Rangel C; Corona-Cedillo R; Escobar-Ceballos S; Garza-Salazar JG
Medicine (Baltimore); 2019 May; 98(19):e15691. PubMed ID: 31083272
[TBL] [Abstract][Full Text] [Related]
18. Posterior reversible encephalopathy syndrome induced by food poisoning in a pediatric patient: a case report.
Wu XM; Wang GL; Kou CG; Wang JT; Liang JM; Yu YQ
J Int Med Res; 2020 Dec; 48(12):300060520980201. PubMed ID: 33349079
[TBL] [Abstract][Full Text] [Related]
19. [Posterior reversible encephalopathy syndrome during nilotinib treatment for chronic myeloid leukemia].
Kudo D; Suzuki H; Abe N; Hirai R; Tanimura A; Takeshita M; Miwa A
Rinsho Ketsueki; 2023; 64(12):1514-1518. PubMed ID: 38220151
[TBL] [Abstract][Full Text] [Related]
20. Posterior Reversible Encephalopathy Syndrome in Patients With Cancer.
Singer S; Grommes C; Reiner AS; Rosenblum MK; DeAngelis LM
Oncologist; 2015 Jul; 20(7):806-11. PubMed ID: 26032137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
